Ansar Jawaid discusses precision medicines – what they are, where we are today and their future

Ansar Jawaid, Founder and CEO of Precision Medicines Ltd, tells us about his talk on precision medicines, what they are, where we are today, the future and some of the challenges involved in their implementation to patients. Precision medicines are matched to patients using biomarkers, enabling to target the specific drivers of various cancers. Major advances have already been made in this field, treating a range of cancers. Some of the major challenges include working with the complexities in different countries, trying to establish diagnostic testing, for enabling precision medicine. He mentions how we are moving towards an era of delivering personalised treatments that are matched to the individual patient. Furthermore, through advances in precision medicines and in diagnostic testing, we are seeing earlier detection of disease and identification of risk factors, allowing for preventative measures.

videos giant health 2016
TOP

We'd love to work with you

Contact Us
London

16-17 Little Portland Street
London
W1W 8BP

+44 (0)20 7291 5070
email

Singapore

8 Cross Street, Level 28
PWC Building
Singapore, 048424

+44 (0)20 7291 5070
email

Suffolk Coast

Basepoint Unit 12a
The Havens
Ransomes Euro Park
Ipswich, IP3 9BF

T. +44 (0)1473 722 794
email

Call Us